FDA inspectors find black mould, bugs at two Chinese GLP-1 compounding plants

FDA inspectors found black mould, filthy floors, bugs in the ceilings and bogus documentation at two Chinese factories producing materials for compounded GLP-1 drugs. The contamination raises safety concerns about compounded weight-loss products sourced from these facilities.

Detected & updated continuously · Source: Nebula